Cytokine production induction

Cytokine production induction is a fundamental immunological process involving the synthesis and release of signaling proteins by cells in response to various stimuli. This process is primarily mediated by the activation of pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), or through the engagement of the T-cell receptor (TCR) complex (Source: NIH/NCBI). In the context of drug development, the induction of specific cytokines is a desired therapeutic outcome for vaccines and cancer immunotherapies, where it helps to prime and direct the immune response against pathogens or malignant cells (Source: Nature Reviews Drug Discovery). Conversely, rapid and systemic cytokine induction is a major safety concern for many biologics and cell therapies, as it can lead to cytokine release syndrome (CRS), a life-threatening condition characterized by high fever and multi-organ dysfunction (Source: Journal of Clinical Oncology). Because "Cytokine production induction" refers to a broad physiological effect or a functional endpoint rather than a specific molecular entity like a receptor or enzyme, it is not classified as a discrete therapeutic target. Instead, it is a pharmacological consequence of targeting specific immune pathways.

Other names

Cytokine inductionCytokine releaseStimulation of cytokine synthesisCytokine production

Activation of pattern recognition receptors (PRRs) or T-cell receptors, leading to downstream signaling through NF-κB, IRF, and MAP kinase pathways to induce cytokine gene expression (Source: Frontiers in Immunology).